Cartiva, a developer of synthetic cartilage and osteoarthritis treatments, announces an $8.3 million Series D round and adds ex-Wright Medical exec Eric Stoookey to its board.
Cartiva said it secured $8.5 million in an over-subscribed Series D financing for developing new products to treat cartilage injuries and osteoarthritis.
The round was led by new investor New Enterprise Assoc. and existing backer Windham Venture Partners, Cartiva said.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zYzpZt
Cap comentari:
Publica un comentari a l'entrada